"In June 2018, we secured Pharmaceutical and Medical Device Agency (“PMDA”) approval to market the CorPath GRX System in Japan. We are working with our distributor towards reimbursement for robotic-assisted PCI as the final step in preparing for the commercial launch of CorPath GRX in Japan, which we expect to occur in the first half of 2019."